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Because of its stringent sequence speciﬁcity, tobacco etch virus (TEV) protease is widely used to remove fusion tags from
recombinant proteins. Due to the poor solubility of TEV protease, many strategies have been employed to increase the expression
level of this enzyme. In our work, we introduced a novel method to produce TEV protease by using visible superfolder green
ﬂuorescent protein (sfGFP) as the fusion tag. The soluble production and catalytic activity of six variants of sfGFP-TEV was
examined, and then the best variant was selected for large-scale production. After puriﬁed by Ni-NTA aﬃnity chromatography
and Q anion exchange chromatography, the best variant of sfGFP-TEV fusion protease was obtained with purity of over 98% and
yield of over 320mg per liter culture. The sfGFP-TEV had a similar catalytic activity to that of the original TEV protease. Our
research showed a novel method of large-scale production of visible and functional TEV protease for structural genomics research
and other applications.
Copyright © 2009 Xudong Wu et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Nowadays, it has been a popular way to fuse target proteins
with various tags to facilitate expression and puriﬁcation.
An eﬃcient combination of solubility-enhancing tags, such
as maltose-binding protein (MBP) [1, 2], N-Utilization
substance (NusA) [3], glutathione S-transferase (GST) [4],
thioredoxin (TRX) [5] ,t r i g g e rf a c t o r[ 6], and SUMO [7],
will promise high-throughput expression and puriﬁcation
methods for many target proteins and sometimes increases
their solubility. However, these fusion tags may become a
drawback for further structural and functional studies [8].
Therefore, the removal of these tags is necessary in many
situations. Proteases such as enterokinase, thrombin, and
factor Xa [9] as well as the more speciﬁc human rhinovirus
3C protease (3CP or PreScission [10]) and tobacco etch virus
(TEV) protease [11] can fulﬁll the task to liberate fusion tags
from target proteins.
The widely used TEV protease is the 27kDa catalytic
domain of the nuclear inclusion an (NIa) protease from
tobacco etch virus [12]. Among various proteases, TEV
protease outstands because of its high and unique speciﬁcity.
It can recognize the canonical cleavage site, ENLYFQ/G
[11] and the P1’ position can tolerate substitutions with
small amino acids [13]. Moreover, TEV protease can be
used at temperature as low as 4◦Cw i t ha d e q u a t ee ﬃciency
to reduce the proteolysis of the target protein. Because
of these advantages, nowadays, it is used more frequently
than other proteases (enterokinase, thrombin, factor Xa,
and human rhinovirus 3C protease) in structural genomic
research projects.
Production of TEV protease in E. coli has been problem-
atic due to its low solubility. To increase its soluble produc-
tion, many strategies have been addressed. First, Kapust et al.
[14] designed a more stable mutant of TEV protease named
S219V. van den Berg et al. [15] obtained a mutant TEVSH
with production of 54mg/L culture by directed evolution.
Later, Fang et al. [16] increased the production to 65mg/L
culture using chaperone coexpression and low-temperature
expression methods. More recently, Blommel and Fox [17]
reported a combined approach raising the production to
400mg/L culture while Kraft et al. developed a ﬂuorogenic
substrate which was useful to determine the TEV protease’s
expression and folding in vivo [18].
Fluorescent protein is widely used as gene reporter and
protein marker, and so forth. However, existing variants of2 Journal of Biomedicine and Biotechnology
green ﬂuorescent protein (GFP) often misfold when fused
to other proteins. P´ edelacq et al. [19] reported a robustly
folded GFP called “superfolder GFP” (sfGFP) which could
fold well regardless of the folding status or solubility of its
fusion partner in E. coli. Furthermore, sfGFP fusions are
more soluble than conventional GFP fusions.
In our present work, considering the high thermody-
namic stability, robust folding kinetics, and solubility of
sfGFP fusions, we tempted to fuse sfGFP to TEV protease
hoping that sfGFP would increase the soluble production
of TEV protease. In order to minimize the possible stereo-
hindrance of sfGFP that might decrease the activity of TEV
protease, we further constructed 6 variants of sfGFP-TEV
with diﬀerent linkers of various lengths and composition
between sfGFP and TEV. Then, the catalytic activity of
sfGFP-TEV variants was tested and compared with that of
the original TEV protease without sfGFP tag. Finally, we
obtained one variant of sfGFP-TEV fusion protease with
solubleproductionofover320mg/Lculture.Comparedwith
the original TEV protease, this variant of sfGFP-TEV has
similar catalytic activity and is easy for detection during
expression, puriﬁcation, and applications because of the
presence of green ﬂuorescence. The results of our work
also present the potential of superfolder GFP to become a
solubility-enhancing fusion tag with ﬂuorescence.
2.MaterialsandMethods
2.1. Materials. The bacterial hosts, E. coli DH5α, Rosetta
(DE3) pLysS, and the vector pET21a were obtained from
Novagen (Madison, WI). KOD Plus polymerase and the
DNA ligation kit were purchased from Toyobo (Osaka,
Japan). Nucleotides, agarose gel, the DNA extraction kit,
and the PCR puriﬁcation kit were purchased from Roche
Diagnostics (Indianapolis, IN). Primer synthesis and DNA
sequence analysis were performed by Invitrogen (Shanghai,
China). Restriction endonucleases were purchased from
Takara (Dalian, China). The nickel-nitrilotriacetic acid
(Ni-NTA) superﬂow matrix was obtained from Qiagen
(Chatsworth, CA). Q Sepharose Fast Flow was from GE
Health (Sweden). Amylose Sepharose was purchased from
New England Biolabs (Hitchin, UK). Bicinchoninic acid
(BCA) Protein Assay Reagent Kit was from Pierce (Rockford,
IL). Imidazole, D-glucose, and D-lactose were from Sigma
(St Louis, MO). All other agents are of analytic purity.
PRK793-TEV expression vector was a gift from Dr. Waugh
[14].
2.2. Construction of sfGFP-TEV and TEV Expression Vectors.
We have previously reconstructed an expression vector,
designated pT7His, which contained the N-terminal His10
and C-terminal His6 tags from the vector pET21a. The
detailed vector construction procedure was similar to that of
pT7470 with N-terminal His6 and C-terminal His6 tags [20].
We optimized the codon usage of superfolder GFP’s cDNA
by referring to its amino acid sequence [19]. The whole
gene synthesis of superfolder GFP was accomplished by 2
rounds PCR with 18 central primers listed in Table 1,o n e
5  primer 5 -GATATACATATGAGCAAAGGCGAAGAA-3 
and one 3  primer 5 -GCCGGATCCGCCCCCGGAACC-
CCCTCCGTTATTGTTATTCTTGTACAGCTCGTCCAT-
3 . Considering that the C-terminal poly (R) in PRK793-
TEV would decrease the solubility of TEV protease [17], we
replaced the poly (R) with residue E to construct the plasmid
TEV 238Δ by PCR with primers 5 -GGGGGTAGCGGC-
GGTGGCAGCGGCGGAGAAAGCTTGTTTAAG-3  and
5 -TTACTCGAGTCATTCATTCATGAGTTGAGTCGC-3 .
We have constructed 6 recombinant sfGFP-TEV fusion
proteins with diﬀerent linkers. The linker region of sfGFP-
TEV-His6 Nd1–6 was listed in Table 2.T h ep l a s m i dT E V
238Δ was also used as the PCR template to produce the
control TEV protease. The PCR product was incorporated
into the expression vector MBP-LTL-His6 [21]. The ﬁnal
expressionvectorMBP-LTL-TEV-His6 whichproducedTEV-
His6 (MBP tag was self-cleaved during expression) was
employed as a control in further experiments.
2.3. Expression of sfGFP-TEV, TEV-His6, and MBP-EGFP.
The expression vectors mentioned above were trans-
formed into E. coli strain Rosetta (DE3) pLysS. After
the colony had grown overnight at 37
◦Ci n5 m Lo fL B
medium with 100μg/mL ampicillin, 0.5mL of the bacte-
rial suspension was transferred into a 2L ﬂask contain-
ing 250mL autoinduction medium. (For 1 liter culture,
we used 4 ﬂasks to ensure the suﬃcient oxygen sup-
ply). The autoinduction medium was prepared as studier’s
original protocol [22]. Standard stock solutions include
20
∗P( 1MN a 2HPO4,1MK H 2PO4,a n d0 . 5M( N H 4)2SO4),
50
∗M (1.25MNa2HPO4,1 . 2 5 M K H 2PO4,2 . 5 M N H 4Cl,
and 0.25MNa2SO4), and 50
∗5052 (25% glycerol, 2.5%
glucose, and 10% D-lactose); the working autoinduction
medium was assembled by adding sterile concentrated stock
solutions into sterile water. When the cells had grown
(250rpm) at 37
◦C to an optical density at 600nm (OD600)
of 0.6 (around 3 hours), the cells were cooled to 19
◦C
and shaken at 250rpm for 20 hours. Finally, the cells
were collected by centrifugation at 6,000×gf o r2 0m i n u t e s
and stored at −80
◦C. In order to reﬂect the real-time
expression level of sfGFP-TEV, the induced E. coli cells in
t h ea u t o i n d u c t i o nm e d i u mw e r ec o l l e c t e da t0 ,2 ,4 ,6 ,8 ,
10, 12, 14, and 16 hours, respectively. The ﬂuorescence of
100μL E. coli cells in the 96-well plates was recorded by DTX
880 multimode detector (Beckman) using bottom reading
method with 485nm excitation ﬁlter and 535nm emission
ﬁlter.
2.4. Puriﬁcation of sfGFP-TEV and TEV-His6. The sfGFP-
TEV-His6 Nd1–6 recombinant proteins were all ﬁrst puriﬁed
by Ni-NTA aﬃnity chromatography. The frozen cell pellet
was thawed and resuspended in Buﬀer A (50mM Tris–HCl
[pH 8.0], 150mMNaCl, 10% [v/v] glycerol, 20mM imida-
zole). Then, the cells were lysed by sonication on ice and the
lysate was cleared by two-round 20-minute centrifugation
at 20,000×g. The retained supernatant was loaded onto a
Ni-NTA Superﬂow column which was pre-equilibrated with
Buﬀer A. After loading, the Ni-NTA column was washedJournal of Biomedicine and Biotechnology 3
Table 1: Primers for whole gene synthesis of superfolder GFP.
No. and length Oligo Sequences (5  → 3 )
S1F 59 ATGAGCAAAGGCGAAGAACTGTTTACCGGCGTGGTGCCGATTCTGGTTGAACTGGATGG
S2R 59 GCCTTCGCCGCGCACGCTAAACTTATGGCCATTAACATCGCCATCCAGTTCAACCAGAA
S3F 59 TAGCGTGCGCGGCGAAGGCGAAGGCGATGCGACCAACGGCAAACTGACCCTGAAGTTTA
S4R 59 AGGGTCGGCCACGGCACCGGCAGTTTGCCGGTGGTGCAAATAAACTTCAGGGTCAGTTT
S5F 59 CGGTGCCGTGGCCGACCCTGGTGACCACCCTGACCTATGGCGTGCAGTGCTTTAGCCGC
S6R 59 CGGACTTAAAGAAATCATGGCGTTTCATGTGATCCGGATAGCGGCTAAAGCACTGCACG
S7F 59 CATGATTTCTTTAAGTCCGCGATGCCGGAAGGCTATGTTCAGGAACGCACCATTAGCTT
S8R 59 TTTCACTTCCGCGCGGGTCTTATAGGTGCCATCATCTTTAAAGCTAATGGTGCGTTCCT
S9F 59 GACCCGCGCGGAAGTGAAATTTGAAGGCGATACCCTGGTGAACCGCATTGAACTGAAAG
S10R 59 TTATGGCCCAGAATGTTGCCATCTTCTTTGAAGTCAATGCCTTTCAGTTCAATGCGGTT
S11F 59 GCAACATTCTGGGCCATAAACTGGAGTACAATTTCAACAGCCATAACGTGTATATTACC
S12R 59 TTTTGAAATTCGCTTTGATGCCGTTCTTCTGTTTGTCCGCGGTAATATACACGTTATGG
S13F 59 ATCAAAGCGAATTTCAAAATCCGCCATAATGTGGAAGATGGCAGCGTGCAGCTGGCGGA
S14R 59 CACCGGGCCATCGCCGATCGGGGTATTCTGCTGATAGTGATCCGCCAGCTGCACGCTGC
S15F 59 GATCGGCGATGGCCCGGTGCTGCTGCCGGACAATCACTACCTGAGCACCCAGTCCGTGC
S16R 54 CATGTGATCGCGTTTCTCATTCGGATCTTTGCTCAGCACGGACTGGGTGCTCAG
S17F 54 TGAGAAACGCGATCACATGGTTCTGCTGGAGTTTGTGACCGCGGCGGGTATCAC
S18R 44 CTTGTACAGCTCGTCCATGCCATGAGTGATACCCGCCGCGGTCA
with Buﬀer A with 40mM imidazole. The column was
equilibrated again with Buﬀer A and then eluted with Buﬀer
B (50mM Tris–HCl [pH 8.0], 150mMNaCl, 10% [v/v]
glycerol, 500mM imidazole). The ﬂuorescence of 100μLN i -
NTA puriﬁcation sample was also recorded by DTX 880
multimode detector (Beckman) using top reading method
with 485nm excitation ﬁlter and 535nm emission ﬁlter.
The collected elution from Ni-NTA aﬃnity chromatog-
raphy was immediately diluted with 5 volume QA (50mM
Tris–HCl [pH 8.0], 10% [v/v] glycerol). The dilution
was loaded onto a Q Sepharose Fast Flow column pre-
equilibrated with QA. After washed with QA, the protein was
eluted with a linear 0–0.9MNaCl gradient by automatically
mixing QA and QB (50mM Tris–HCl [pH 8.0], 1MNaCl,
10% [v/v] glycerol). Fractions were analyzed by SDS-PAGE
and quantiﬁed by BandScan 4.30 (Glyko) and were pooled
based on their purity and concentration. The concentra-
tion of pooled protein sample from Q anion exchange
chromatography and elution sample from Ni-NTA aﬃnity
chromatography was determined by BCA method according
to the reagent kit protocol (Pierce). The pooled protein
was dialyzed in dialysis buﬀer (50mM Tris–HCl [pH 8.0],
150mMNaCl, 0.5mM EDTA, 10% [v/v] glycerol) at 4◦C
and then diluted with storage buﬀer (50mM Tris–HCl [pH
8.0], 150mMNaCl, 0.5mM EDTA, 80% [v/v] glycerol) to
a protein concentration of ∼2mg/mL in 40% glycerol. The
puriﬁed protein was ﬁnally stored at −20
◦C.
TEV-His6 was puriﬁed by Ni-NTA aﬃnity chromatogra-
phy using the similar methods described above. The puriﬁed
protein was dialyzed in dialysis buﬀer and diluted with
storage buﬀer to a protein concentration of ∼1mg/mL
in 40% glycerol. The puriﬁed TEV-His6 was stored at
−20
◦C.
2.5. Puriﬁcation of TEV Protease Substrate MBP-EGFP.
For the puriﬁcation of MBP-EGFP, the cell pellet was
thawed and resuspended in Amylose A buﬀer (50mM
Tris–HCl [pH 8.0], 150mMNaCl, 10% [v/v] glycerol). After
sonication, the supernatant was retained by two-round
20-minute centrifugation at 20,000×g and then loaded
onto the Amylose Sepharose Column pre-equilibrated with
Amylose A buﬀer. MBP-EGFP was eluted with Amylose B
buﬀer (50mM Tris–HCl [pH 8.0], 150mMNaCl, 10% [v/v]
glycerol, 20mM maltose). The puriﬁed protein sample was
analyzed by SDS-PAGE and quantiﬁed by BandScan 4.30
(Glyko). The puriﬁed MBP-EGFP was dialyzed in dialysis
buﬀer (150mMNaCl, 10% [v/v] glycerol, 1mM EDTA) at
4◦Ca n dt h e ns t o r e da t4 ◦C.
2.6. Activity Assay of sfGFP-TEV and TEV-His6. The cat-
alytic activity of sfGFP-TEV-His6 Nd1–6 and TEV-His6 was
determined by cleaving the substrate MBP-EGFP which
contained a TEV cleavage site between MBP and EGFP. Prior
to activity assay, the protein concentration of sfGFP-TEV-
His6 Nd1–6, TEV-His6, and MBP-EGFP was determined by
BCA method according to the reagent kit protocol (Pierce).
The time course assay was conducted at 17
◦Cf o rag i v e n
incubation time (0, 5, 10, 20, 40, 60, 90, 120, 180, and 240
minutes, respectively). The mass ratio of substrate to enzyme
(calculated by the mass of eﬀective TEV protease) is 100 :
1. At any given time, the reaction was stopped by adding
3×loadingbuﬀer(150mMTris-HCl[pH6.8],300mMDTT,
6% [w/v] SDS, 0.06% [w/v] bromophenol blue, 30% [v/v]
glycerol). The samples were boiled at 95
◦Cf o r3m i n u t e s
andthenloadedonto12%SDS-PAGEgelforelectrophoresis.
After visualized by staining with Coomassie G-250, the gel
was quantiﬁed by BandScan 4.30 (Glyko) to establish the4 Journal of Biomedicine and Biotechnology
Table 2: Linker region of sfGFP-TEV-His6 Nd1–6.
Construction Code Abbreviation Linker length
(aa)
Anticipated linker composition
SfGFP-TEV-His6 Nd1 Nd1 2 ...THG/GS/RD...
SfGFP-TEV-His6 Nd2 Nd2 5 ...THG/GSKGP/RD...
SfGFP-TEV-His6 Nd3 Nd3 8 ...THG/NNPGSKGP/RD...
SfGFP-TEV-His6 Nd6 Nd6 8 ...THG/GSNLFKGP/RD...
SfGFP-TEV-His6 Nd4 Nd4 11 ...THG/NNPGSNLFKGP/RD...
SfGFP-TEV-His6 Nd5 Nd5 14 ...THG/MDPNNPGSNLFKGP/RD...
lacI
Nde I
Ori
pT7His
Amp-r
f1 origin
His6
Xho I
TEV Linker
BamHI
sf GFP
Xho I
Nde I
Nde I
Coding region
BamHI
Figure 1: Maps of expression vector for sfGFP-TEV-His6 Nd1–
6 used in our work. The vector map was created by Vector NTI
software. All variants of sfGFP-TEV-His6 use the same vector
pT7His derived from pET21a. The coding region in black will
produce sfGFP-TEV-His6 Nd1–6.
time-course curve. The reaction condition was 75mMNaCl,
0.5mM EDTA, 25mM Tris-HCl 8.0, and 10% [v/v] glycerol.
3. Results andDiscussion
3.1.ConstructionofExpressionVectorforsfGFP-TEVandTEV.
In order to maximize the expression level of the recombinant
sfGFP-TEV proteases, we ﬁrst synthesized the sfGFP gene
according to the synonymous codon choice which is optimal
for the Escherichia coli translational system. Figure 1 shows
the vector map we used for high-level expression of sfGFP-
TEV-His6 Nd1–6. The sfGFP-TEV coding sequence was
cloned to the pET derived vector pT7His which possesses
the strong bacteriophage T7 promoter, ensuring the high
level expression of target protein. Considering that the linker
between sfGFP and TEV might have eﬀects on the stability
and catalytic activity of fusion protease, we constructed
6 variants of sfGFP-TEV-His6 with diﬀerent linkers. The
linker here is deﬁned as the peptide between C-terminus
of sfGFP “THG” and N-terminus of TEV “RDYNP.” The
composition of diﬀerent linkers with lengths varying from 2
to 14aa could be referred to Table 2. We also incorporated
a small peptide “GGG” at the C-terminus of TEV; so the
C-terminuses of sfGFP-TEV-His6 Nd1–6 and TEV-His6 are
all “LMNEGGGLEHHHHHH.” Our ﬁrst attempt of sfGFP-
TEVvectorconstructiondidnotincludetheGGGsmallpep-
tidebetweenTEVandC-terminusHis6tag.However,during
the Ni-NTA puriﬁcation step, more than 70% expressed
fusion protein did not bind with the Ni-NTA resin (data not
shown). Perhaps the steric structure of TEV hindered His6
tagfrombindingwithNi-NTAresin.Soweaddedtheﬂexible
GGG peptide between TEV and His6 tag. Almost all of the
new version fusion protein can bind with Ni-NTA in the
buﬀer containing relatively high concentration (20mM) of
imidazole.
3.2. Fusion of sfGFP to TEV Greatly Increases the Soluble
Production of TEV Protease. After autoinduction, sfGFP-
TEV-His6 Nd1–6 were all puriﬁed by Ni-NTA aﬃnity
chromatography and Q anion exchange chromatography.
After puriﬁcation, there was an obvious main band around
the molecular weight of 53kDa (Figures 2(a) and 2(b)).
Table 3 summarizes the puriﬁcation results from 1-L cul-
ture medium. According to Bandscan software analysis, all
variants of fusion protease were obtained with over 96%
purity. Among them, Nd2, Nd4, and Nd5 were puriﬁed
with over 98% purity. With the fusion of sfGFP, all
variants could be puriﬁed by two-step chromatography with
soluble production of over 200mg. In particular, we could
obtain around 320mg of sfGFP-TEV Nd2 from 1-L culture
medium. Because the molecular weight of sfGFP-TEV Nd2
and TEV-His6 was 53.8kDa and 28.8kDa, respectively,
320mg/L of sfGFP-TEV Nd2’s eﬀective TEV composition
was close to 171mg/L (320 ∗ 28.8/53.8 = 171) of TEV-
His6. We also constructed the control expression vector for
TEV protease without any tags, but there was almost no
detectable TEV protease expressed under the same induction
condition (data not shown). Therefore, the fusion of sfGFP
to TEV signiﬁcantly increases the soluble production of TEV
protease.
3.3. Puriﬁcation of TEV-His6 and MBP-EGFP. We have also
expressed and puriﬁed TEV-His6 as control and MBP-EGFP
as TEV protease’s substrate. During expression, the MBP
tag of MBP-LTL-TEV-His6 would be cleaved and then TEV-
His6 was released. By Ni-NTA aﬃnity chromatography and
furtherdialysis,about140mgofTEV-His6 couldbeobtained
from 1-L culture medium with around 98% purity. TheJournal of Biomedicine and Biotechnology 5
TEV Nd2
123M4567M
(kDa)
86.9
66.2
47.4
37.7
29
(a)
Nd1 Nd3 Nd4 Nd5 Nd6
M Ni Q Ni Q Ni Q Ni Q Ni Q
(kDa)
86.9
66.2
47.4
37.7
29
(b)
Figure 2: SDS-PAGE analysis of the expression and puriﬁcation of sfGFP-TEV-His6 Nd1–6 and TEV-His6. (a) Lanes 1–3 are the result for
TEV-His6:Lane1:autoinducedwhole-bacteriallysate;Lane2:ﬂowthroughfromNi-NTAaﬃnitychromatography;Lane3:thepuriﬁedTEV-
His6 eluted from Ni-NTA aﬃnity chromatography. Lanes 4–7 are the result for sfGFP-TEV-His6 Nd2: Lane 4: autoinduced whole-bacterial
l y s a t e ;L a n e5 :ﬂ o wt h r o u g hf r o mN i - N T Aa ﬃnity chromatography; Lane 6: the puriﬁed sfGFP-TEV-His6 Nd2 eluted from Ni-NTA aﬃnity
chromatography;Lane7:thepooledsampleofpuriﬁedsfGFP-TEV-His6 Nd2elutedfromQanionexchangechromatography.(b)Theresults
for sfGFP-TEV-His6 Nd1 and Nd3–6. “Ni” represents the results of the puriﬁed protein eluted from Ni-NTA aﬃnity chromatography; “Q”
represents the pooled sample of puriﬁed protein eluted from Q anion exchange chromatography. “M” in (a) and (b) represents the protein
marker.
Table 3: Puriﬁcation results of sfGFP-TEV-His6 Nd1–6 and TEV-His6 collected from 1-L of expression culture medium.
Abbreviation Theoretical
MW (kDa)
Total protein after
Ni-NTA (mg)
Purity Total protein after
High Q (mg)
Purity Total activity
(μmol/h)
Speciﬁc activity
(μmol/h/mg)
Nd1 53.5 244 ±1 90% 221 ±2 96% 7.3 ±0.20 .067 ±0.002
Nd2 53.8 334 ±2 94% 323 ±1 98% 13.7 ±0.30 .085 ±0.002
Nd3 54.1 220 ±4 93% 211 ±3 97% 8.0 ±0.10 .076 ±0.001
Nd4 54.5 304 ±6 93% 293 ±4 98% 11.9 ±0.50 .082 ±0.003
Nd5 55.0 299 ±1 93% 288 ±2 98% 11.3 ±0.60 .079 ±0.005
Nd6 54.2 308 ±5 93% 300 ±4 96% 12.0 ±0.50 .080 ±0.003
TEV 28.8 140 ±3 98% — — 12.6 ±0.60 .090 ±0.005
electrophoresis results show that molecular weight of TEV-
His6 is around 29kDa (Figure 2(a)). The substrate MBP-
EGFP could also be puriﬁed with over 95% purity by
Amylose aﬃnity chromatography.
3.4. Cleavage Activity Assay of sfGFP-TEV and TEV. The
cleavage activity assay of sfGFP-TEV-His6 Nd1–6 and TEV-
His6 could be determined by cleaving the substrate MBP-
EGFP at the cleavage site “ENLYFQ/G” between MBP
and EGFP. By SDS-PAGE, the remaining MBP-EGFP could
be separated suﬃciently with released MBP and EGFP
(Figure 3(a)). After we set the quantity of MBP-EGFP at 0
min as 100%, the time course curve could be plotted by
quantitatively analyzing the digested MBP-EGFP at the given
time.Figure 3(b)showsthetimecoursecurveofsfGFP-TEV-
His6 Nd1–6, TEV-His6,a n d2 %T E V - H i s 6. Compared with
the time course curve of TEV-His6, we found that sfGFP-
TEV-His6 Nd1–6 had diﬀerent degrees of loss of catalytic
activity. Among them, Nd2 had the closest curve to TEV-
His6. Ranking the cleavage rate at 60 minutes, the second
highest ranked Nd2 could digest around 66% substrate,
which retained about 95% catalytic activity of TEV-His6.
Moreover, TEV-His6 and all variants of sfGFP-TEV-His6
except Nd1 could eﬃciently cleave over 98% substrate after
incubation for 4 hours at 17
◦C. However, the control 2%
TEV-His6 could only cleave less than 7% substrate under
thesamecondition(Figure 3(c)).Inconclusion,sfGFP-TEV-
His6 Nd2 retained the most of catalytic activity among all
variants.
Fusion tags are widely used to facilitate protein expres-
sion and puriﬁcation. However, due to its drawback in
structural and functional studies, these tags always need
to be removed by various proteases. TEV protease is an
ideal protease receiving most attention, thanks to its high
speciﬁcity as well as toleration of a wide range of temper-
atures and presence of detergents [23]. One bottleneck for
T E Vp r o t e a s ei sl o ws o l u b l ep r o d u c t i o nd u et oi t sp o o r
solubility. Researchers have tried many strategies including
in silico design [24], direct-evolution [15], or coexpression
with chaperone to increase its soluble production. These
eﬀorts have raised the production from 1mg/L to 65mg/L
culture [16]. More recently, Blommel and Fox reported a6 Journal of Biomedicine and Biotechnology
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Figure 3: SDS-PAGE and time course analysis of catalytic activity on MBP-EGFP of sfGFP-TEV-His6 and TEV-His6. (a) One representative
of SDS-PAGE analysis. 100μg MBP-EGFP was incubated with 2μg sfGFP-TEV-His6 Nd2. Lane 1 is the protein marker. Lanes 2–11 represent
diﬀerent incubation time (0, 5, 10, 20, 40, 60, 90, 120, 180, 240 minutes, resp.). (b) The time course curve analysis. The time course curve
was plotted according to the quantitative analysis of the SDS-PAGE by Bandscan 4.30. Each data point was the average of three independent
tests. (c) Bar representation based on time course curve. The black bars represent the percentage of the digested MBP-EGFP after incubation
for 60 minutes. The striped bars represent the percentage after incubation for 240 minutes. The ranking of the bar is based on the sorting
result of cleavage eﬃciency after incubation for 60 minutes. The height of the bar is the average of three independent tests with standard
error on top of the bar.
production of 400mg/L culture by optimizing each step
in expression, and puriﬁcation [17]. However, the whole
process of expression, puriﬁcation and characterization of
recombinant TEV protease was not visible to naked eye. Our
attempts to express recombinant TEV protease fused with
commonlyusedGST,TRX,andNusAtagsallfailed(datanot
shown). GST and TRX fused TEV proteases were most in the
inclusion body and NusA fusion strategy gave less than 50%
full length fusion protein.
In this paper, we introduce a novel method to increase
the soluble production of TEV protease by fusing sfGFP
to TEV protease. The results show that the production
of sfGFP-TEV-His6 Nd2 fusion protease reached 320mg/L
culture. Thanks to sfGFP’s high folding kinetics, thermo-
dynamic stability, sfGFP might work as a platform for
the folding of TEV protease to prevent the formation of
inclusion body. Compared with MBP which brings high
metabolic burden for the host, sfGFP is much smaller and
has ﬂuorescence easy for detection. Figure 4 showed that
the expression (Figure 4(a)) and puriﬁcation (Figure 4(b))
procedure of sfGFP-tagged fusion protein can be monitored
and quantiﬁed real-time by the ﬂuorescence emitted from
sfGFP, thus greatly simpliﬁed the procedure of sfGFP tagged
target proteins expression and puriﬁcation. We suggest that
sfGFP could be employed as a colored solubility-enhancing
tag for other small proteins with poor soluble production.
Catalytic activity is another important factor to be
examined in our work. We constructed 6 variants of sfGFP-
TEV-His6 in all. The catalytic tests show that sfGFP-TEV-
His6 Nd2 with a linker of only ﬁve residues “GSKGP” has
the closest catalytic activity to TEV-His6. After one-hour
incubation at 17
◦C, over 65% MBP-EGFP could be cleavedJournal of Biomedicine and Biotechnology 7
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Figure 4: The quantiﬁcation of sfGFP ﬂuorescence during sfGFP-
TEV-His6 Nd2 expression and puriﬁcation. (a) The ﬂuorescence
intensity versus time curve of sfGFP-TEV-His6 Nd2 by autoinduc-
tion at 19
◦C. The ﬂuorescence of 100μL cultured E. coli cells in the
autoinductionmediumwascollectedusingbottomreadingmethod
with 485nm excitation ﬁlter and 535nm emission ﬁlter. The height
of the bar is the average of three independent tests with standard
e r r o ro nt o po ft h eb a r .( b )O n er e p r e s e n t a t i v esfGFP ﬂuorescence
quantiﬁcation during Ni-NTA puriﬁcation. The ﬂuorescence was
collected using top reading method with 485nm excitation ﬁlter
and 535nm emission ﬁlter. (−): uninduced cell lysate; (+): induced
whole cell lysate; S↑: supernatant of the sonication; F.T.: ﬂow
through fraction from Ni-NTA chromatography; Wash: wash
fraction from Ni-NTA chromatography; E.: eluated fraction by
imidazole from Ni-NTA chromatography.
by sfGFP-TEV-His6 Nd2 while TEV-His6 cleaved around
70% substrate (Figure 3). In contrast, sfGFP-TEV-His6 Nd1
has the lowest speciﬁc activity, which might be explained
by the importance of three residues “KGP” on the correct
folding and stability of TEV protease.
When preserved in 4◦C for a long time, TEV-His6
was not stable and would precipitate and completely lose
the catalytic activity within one week (data not shown).
However, sfGFP-TEV-His6 Nd2 would not precipitate for
more than one month and still retained about 60% catalytic
activity, which showed much higher stability than original
TEV-His6.T h esfGFP tag not only increased the solubility of
thetargetproteinduringexpressionandpuriﬁcationbutalso
increased its stability. Though the increase of eﬀective TEV
protease yield of sfGFP-TEV was only ∼22% (from 140mg
to 171mg TEV-His6 per liter culture), during the long time
cleavage experiment, the increased stability of sfGFP-TEV
signiﬁcantly outrun the original TEV protease widely used.
This feature is vital because structural genomics required
large-scale production of tag-free target proteins by TEV
protease. Besides, the ﬂuorescence characteristic of sfGFP
tag provided an accurate, visible, and high-throughput
measurement to quantify the fused target protein. The trace
existence of sfGFP tagged TEV can be sensitive and easily
detected by spectroﬂuorometer. By detecting the sfGFP
ﬂuorescence intensity, we can also accurately quantify the
recombinant sfGFP-TEV protease. Like the original TEV
protease, the His6 tag of sfGFP-TEV makes it very easy to
remove sfGFP-TEV from cleaved target protein by Ni-NTA
chromatography after cleavage experiment.
In nature, evolution has shown its power of merging
diﬀerent domains to create a novel enzyme with great
property. With rational design, we can also take advantage
of available proteins to improve the property of certain
enzymes. Our research showed that sfGFP tag signiﬁcantly
improvedthesolubility,expressionlevel,andstabilityofTEV
protease, which is important for the large-scale production
of functional TEV protease used in structural genomics
research.
Abbreviations
BCA: Bicinchoninic acid
GFP: Green ﬂuorescent protein
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TRX: Thioredoxin.
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